Aurobindo Pharma Ltd
BSE:524804
Aurobindo Pharma Ltd
BSE:524804
Price:
1 339.65
INR
-0.77%
Market Closed
Market Cap:
₹785B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aurobindo Pharma Ltd
BSE:524804
|
IN |
|
IQE PLC
LSE:IQE
|
UK |
|
S
|
Solize Corp
TSE:5871
|
JP |
|
Advancer Global Ltd
SGX:43Q
|
SG |
|
O
|
Oriental Interest Bhd
KLSE:OIB
|
MY |
|
Greenbrook TMS Inc
TSX:GTMS
|
CA |
|
Ono Pharmaceutical Co Ltd
TSE:4528
|
JP |
|
S
|
Sescom SA
WSE:SES
|
PL |
|
H
|
Hanil Cement Co Ltd
KRX:300720
|
KR |
|
A
|
Advanced Optoelectronic Technology Inc
TWSE:3437
|
TW |
|
Reconditioned Systems Inc
OTC:AMXX
|
US |
|
K
|
Kyverna Therapeutics Inc
NASDAQ:KYTX
|
US |
|
T
|
TYM Corp
KRX:002900
|
KR |
|
K
|
Kerur Holdings Ltd
TASE:KRUR
|
IL |
|
Y
|
Yonyu Plastics Co Ltd
TWSE:1323
|
TW |
|
Musashi Seimitsu Industry Co Ltd
TSE:7220
|
JP |
|
B
|
Business Engineering Corp
TSE:4828
|
JP |
|
Samick Musical Instruments Co Ltd
KRX:002450
|
KR |
|
Kansai Nerolac Paints Ltd
NSE:KANSAINER
|
IN |
|
A
|
Argenta Silver Corp
OTC:AGAGF
|
CA |
|
C
|
CPM Group Ltd
HKEX:1932
|
HK |
|
V
|
Vrain Solution Inc
TSE:135A
|
JP |
|
Universal Inc
TWSE:1325
|
TW |
|
G
|
Gopeng Bhd
KLSE:GOPENG
|
MY |
Multiples-Based Value
The
Multiples-Based Value for
Aurobindo Pharma Ltd (524804)
under the Base Case is
hidden
INR.
Compared with the current market price of 1 339.65 INR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AUROPHARMA Multiples-Based Value
LOCKED
Multiples Across Competitors
AUROPHARMA Competitors Multiples
Aurobindo Pharma Ltd Competitors
Aurobindo Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Aurobindo Pharma Ltd
BSE:524804
|
778.2B INR | 2.4 | 22.6 | 10.6 | 14.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD | 13 | 41.2 | 27.8 | 29.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD | 6.1 | 21.4 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP | 5.2 | 29.7 | 16.4 | 23.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP | 2.7 | 15.2 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
